𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clearance constants in physiologically based pharmacokinetic models

✍ Scribed by Hsiao-Sheng George Chen; Joseph F. Gross


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
218 KB
Volume
68
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Evaluation of physiologically based phar
✍ Weihsueh A. Chiu; Hugh A. Barton; Robert S. DeWoskin; Paul Schlosser; Chad M. Th πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 191 KB

## Abstract Physiologically based pharmacokinetic (PBPK) models are sophisticated dosimetry models that offer great flexibility in modeling exposure scenarios for which there are limited data. This is particularly of relevance to assessing human exposure to environmental toxicants, which often requ

Physiologically based pharmacokinetic mo
✍ Kannan Krishnan; Lee C.B. Crouse; Matthew A. Bazar; Michael A. Major; Gunda Redd πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 369 KB

## Abstract A physiologically based pharmacokinetic (PBPK) model for simulating the kinetics of cyclotrimethylene trinitramine (RDX) in male rats was developed. The model consisted of five compartments interconnected by systemic circulation. The tissue uptake of RDX was described as a perfusion‐lim

Physiologically based pharmacokinetic (P
✍ Olivier Luttringer; Frank-Peter Theil; Patrick Poulin; Anne H. Schmitt-Hoffmann; πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 256 KB

The objective of this study was to use in synergy physiologically based and empirical approaches to estimate the drug-specific input parameters of PBPK models of disposition to simulate the plasma concentration-time profile of epiroprim in human. The estimated input parameters were the tissue:plasma

Prediction of pharmacokinetics prior to
✍ Patrick Poulin; Frank-Peter Theil πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Many in vitro data on physicochemical properties and specific absorption, distribution, metabolism, and elimination (ADME) processes are already available at early stages of drug discovery. These data about new drug candidates could be integrated/ connected in physiologically based pharmacokinetic (